Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
Ovarian cancer is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival rates, it is necessary to integrate alternative strategies to improve the outcomes. Advances in un...
Saved in:
Main Authors: | Francesca De Felice, Claudia Marchetti, Innocenza Palaia, Daniela Musio, Ludovico Muzii, Vincenzo Tombolini, Pierluigi Benedetti Panici |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2015/191832 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvar Malignancy in Neurofibromatosis Syndrome
by: Angela Musella, et al.
Published: (2013-01-01) -
Pelvic Inflammatory Disease: Possible Catches and Correct Management in Young Women
by: Chiara Di Tucci, et al.
Published: (2018-01-01) -
Immunotherapeutic Potential of Lactobacillus Species as Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Renukadevi J, et al.
Published: (2025-01-01) -
Immunotherapy in Recurrent Ovarian Cancer
by: Keyao Chen, et al.
Published: (2025-01-01) -
Case report: Short-course hypofractionated radiation therapy combined with immune checkpoint inhibitors for the treatment of advanced ovarian mucinous cystadenocarcinoma
by: Xinan Wan, et al.
Published: (2025-01-01)